ORLANDO, Fla. — Okava Pharmaceuticals has launched a pilot program testing GLP-1 injections for obese cats, according to a report in The New York Times. The program involves an implant slightly larger ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback